AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(14 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
 
* ''AXA Full Year 2025'' earnings presentation delivered on February Earnings26, Presentation2026 <sup>p. 1</sup>
* February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* Certain''Forward-looking statements'' are forward-looking, includinginclude predictions of future events, trends, plans, expectations, or objectives, andbased are identified by words likeon Management'expects',s 'anticipates',current 'may',views 'plan,'and 'target'subject orto conditional verbs such as 'would' and 'could'change <sup>p. 2</sup>.
* Statements regarding expected '''underlyingExpected earningsUEPS per sharegrowth''' ('UEPS') growth for 2026 areis forward-looking statementsprovided providingas one-off guidance forin the context of the lastfinal year of the Group's current strategic plan <sup>p. 2</sup>.
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer''Financial to Part 5statements status'Risk Factors and Risk Management' of: AXA's Universalconsolidated Registrationfinancial Documentstatements for the year ended December 31, 20242025 (thewere '2024examined Universalby Registrationthe Document')Board forof aDirectors descriptionon ofFebruary important factors25, risks2026, and uncertaintiesare subject to completion of audit procedures <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and financial position <sup>p. 2</sup>.
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>.
* None of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS <sup>p. 2</sup>.
* '''Underlying earnings''', UEPS ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015 <sup>p. 2</sup>.
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on page 04 <sup>p. 3, 4</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on page 09 <sup>p. 3, 9</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on page 13 <sup>p. 3, 13</sup>.
 
== FY25 Highlights ==
 
* Section divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
=== 1 FY25 Highlights ===
 
* FY25 Highlights <sup>p. 4</sup>
* Thomas Buberl, Group CEO <sup>p. 4</sup>
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
{| class="wikitable fintable"
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
*|+ '''ROE'''Key FY25:financial 16%highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
* '''Solvency II ratio''' FY25: 224% <sup>p. 5</sup>
! class="col-m" style="text-align:right" | Value
* Delivering value for shareholders with '''DPS''' +8% growth and EUR 1.25bn annual share buy back <sup>p. 5</sup>.
|-
** DPS growth is based on the dividend proposed by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>.
| style="text-align:left" | Revenues growth vs. FY24
** The annual share buy back follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>.
| style="text-align:right" | +6%
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>.
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS outlook for 2026
| style="text-align:right" | Upper end of 6%-8% target range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
 
=== Executing the plan on growth, margin and efficiency ===
Line 69 ⟶ 77:
{| class="wikitable fintable"
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs(constant FY24FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
Line 78 ⟶ 87:
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying earnings (excluding AXA IM)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +9%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
 
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* '''High organic growth''': +6% top line growth, well balanced across lines <sup>p. 6</sup>
* Scaling the business: Continued investments in growth and technology
** P&C: +5% <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence
** Life: +9% <sup>p. 6</sup>
** Health: +5% <sup>p. 6</sup>
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>.
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 111:
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
 
* '''Secular trends'' fuelingfuel demand across businesses''':, driven by protection gaps and emerging corporate risks, as well as demographics driving demand for private retirement <sup>p.and 7</sup>healthcare
* ''Our right to win'' is supported by four strategic pillars:
** Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup>
** Leading brand & high customer NPS
** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
** Strong and diversified distribution
* '''Our right to win''': <sup>p. 7</sup>
** Technical expertise to price & underwrite risks
** Leading brand & high customer NPS <sup>p. 7</sup>
** Scale offering cost advantage
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
* Pie chart represents FY25 gross written premium split excluding AXA IM and holdings <sup>p. 7</sup>.
 
=== Laying the foundation for the next plan ===
 
* ''Strategic pillars'' established to lay the foundation for the next plan:
* (icon) '''Clear tech and AI roadmap''' <sup>p. 8</sup>
* (icon)* '''DrivingClear efficiency'tech'' and AI roadmap <sup>p. 8</sup>
** (icon)''Driving efficiency'''Enhancing capitalacross allocation discipline'''operations <sup>p. 8</sup>
* (icon)* '''BuildingEnhancing resilience'capital'' allocation discipline <sup>p. 8</sup>
** Confidence''Building inresilience'' sustainingacross earningsthe growthbusiness <sup>p. 8</sup>
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
== Business Performance ==
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* FY25 Business Performance <sup>p. 9</sup>
 
=== FY25 business performance ===
== Strong delivery across our businesses ==
 
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
=== Strong delivery across our businesses ===
 
* '''France'Premium growth basis'': (27%change offor totalgross GWP¹):written premiums is at constant scope and FX <sup>p. 10</sup>.
** '''GrossEarnings writtengrowth premiums'basis'': +6%change tofor EURunderlying 31bnearnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
** '''Underlying earnings''' +7% to EUR 2.2bn <sup>p. 10</sup>
 
* '''Europe''' (38% of total GWP¹): <sup>p. 10</sup>
<div style="overflow-x:auto">
** '''Gross written premiums''' +6% to EUR 43bn <sup>p. 10</sup>
{| class="wikitable"
** '''Underlying earnings''' +9% to EUR 3.5bn <sup>p. 10</sup>
*|+ '''AXAGross XL'''written (17%premiums ofand totalunderlying GWP¹):earnings by region FY25 <sup>p. 10</sup>
! style="text-align:left" | Region (share of total GWP¹)
** '''Gross written premiums''' +4% to EUR 19bn <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Gross written premiums
** '''Underlying earnings''' +9% to EUR 1.9bn <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Underlying earnings
* '''Asia, Africa & EME-LATAM''' (18% of total GWP¹): <sup>p. 10</sup>
|-
** '''Gross written premiums''' +13% to EUR 20bn <sup>p. 10</sup>
| style="text-align:left" | ''France'' (27% of total GWP¹)
** '''Underlying earnings''' +6% to EUR 1.5bn <sup>p. 10</sup>
| class="col-m" style="text-align:right" | +6% to EUR 31bn
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
|}
</div>
 
=== P&C | Strong margins, confidence in sustaining growth ===
 
* '''UnderlyingGross written earnings'premiums'' +9%(GWP) toreached EUR 5.9bn (change FY25 vs. FY24 at constant FX)58bn <sup>p. 11</sup>.
* (donut) '''GWP mix''': EURRetail, 58bnAXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
** '''Retail''':AXA 34%XL GWP includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
** '''SME &Underlying Mid-marketearnings''': 33+9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
** '''AXA XL''' (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) <sup>p. 11</sup>
* (diagram)* '''2025 Strategic Focus''': Growing volumes while expanding margins <sup>p. 11</sup>.
** '''Retail andBeyond SME & Mid-market'2025'': GrowingInvesting volumesto whileimprove customer retention and expanding marginsdistribution footprint <sup>p. 11</sup>.
** '''AXA XL''' (Large & Specialty):'' Profitablestrategic growth with stable margins <sup>p. 11</sup>outlook:
* (diagram)* ''2025'Beyond': 2025Profitable Strategicgrowth Focus'''with stable margins <sup>p. 11</sup>.
** '''RetailBeyond and SME & Mid-market'2025'': InvestingCapitalizing toon improveattractive customergrowth retentionopportunities &and expandingcontinued distributioncycle footprintmanagement <sup>p. 11</sup>.
* ''Earnings drivers'' supporting performance:
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
** (diagram)Continued '''Additionalprogress Strategicon Initiatives'''efficiency <sup>p. 11</sup>.
** ContinuedHigher progressinvestment on efficiencyincome <sup>p. 11</sup>.
** HigherData investment& incomeAI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
** Data & AI to further enhance customer experience & technical excellence <sup>p. 11</sup>
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* '''UnderlyingGross written earnings'premiums'' +7%(GWP) toreached EUR 3.5bn (change FY25 vs. FY24 at constant FX)57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
 
== Financial Performance ==
 
=== FY25 financial performance ===
 
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP split& other revenues by segment, EURFY24 57bnvs totalFY25 <sup>p. 1214</sup>
! style="text-align:left" | SegmentEUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ShareFY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
|-
| style="text-align:left" | Short-termCommercial lines
| style="text-align:right" | 28%
| style="text-align:right" | 35.8
| style="text-align:right" | +4%
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
| style="text-align:left" | Long-termAXA XL Reinsurance
| style="text-align:right" | 72%
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
| style="text-align:right" | +0.3%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | —
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
| style="text-align:right; font-weight:bold" | +5%
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
 
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* (diagram) '''2025 Strategic Focus''' <sup>p. 12</sup>
* Growth supported by alternative capital
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
* (diagram) '''Beyond 2025 Strategic Focus''' <sup>p. 12</sup>
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 12</sup>
** Focus on cost reduction <sup>p. 12</sup>
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
 
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle <sup>p. 13</sup>
* Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
 
* (stacked bar) '''GWP & Other Revenues''' <sup>p. 14</sup>
** '''FY24 Total''': EUR 56.5bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 18.1bn <sup>p. 14</sup>
** '''FY25 Total''': EUR 58.0bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 19.7bn <sup>p. 14</sup>
* '''Commercial lines''': +4% change (o/w pricing +2%, o/w volume +2%) <sup>p. 14</sup>
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* '''AXA XL Reinsurance''': +8% change (o/w pricing +0.3%, o/w volume +7%) <sup>p. 14</sup>
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
** Growth supported by alternative capital <sup>p. 14</sup>
* '''Retail lines''': +7% change (o/w pricing +5%, o/w volume +2%) <sup>p. 14</sup>
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
* Change at constant scope and FX <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
 
<div style="overflow-x:auto">
* (stacked bar) '''Combined ratio''' <sup>p. 15</sup>
{| class="wikitable fintable"
** '''FY24 Total Combined Ratio''': 91.0% <sup>p. 15</sup>
***|+ Undiscounted CY lossCombined ratio (exbridge, NatFY24 Cat):vs 67.4%FY25 <sup>p. 15</sup>
! style="text-align:left" | Combined ratio
*** Expense ratio: 25.0% <sup>p. 15</sup>
! class="col-s" style="text-align:right" | FY24
*** Nat Cat: 3.8% <sup>p. 15</sup>
! class="col-s" style="text-align:right" | FY25
*** Prior year reserve development: -1.6% <sup>p. 15</sup>
|-
*** Discount: -3.6% <sup>p. 15</sup>
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
** '''FY25 Total Combined Ratio''': 90.6% <sup>p. 15</sup>
| style="text-align:right" | 67.4%
*** Undiscounted CY loss ratio (ex Nat Cat): 67.0% <sup>p. 15</sup>
| style="text-align:right" | 67.0%
*** Expense ratio: 24.8% <sup>p. 15</sup>
|-
*** Nat Cat: 3.4% <sup>p. 15</sup>
| style="text-align:left" | Expense ratio
*** Prior year reserve development: -1.1% <sup>p. 15</sup>
| style="text-align:right" | 25.0%
*** Discount: -3.5% <sup>p. 15</sup>
| style="text-align:right" | 24.8%
* Better undiscounted current year loss ratio excluding Nat Cat from: <sup>p. 15</sup>
|-
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
| style="text-align:left" | Nat Cat
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
| style="text-align:right" | 3.8%
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
| style="text-align:right" | 3.4%
* Nat Cat charges below normalized load <sup>p. 15</sup>
|-
* Lower reliance on prior year reserve development <sup>p. 15</sup>
| style="text-align:left" | Prior year reserve development
* Taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total combined ratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Prior year reserve development shows lower reliance
* Reserve prudence enhanced by taking advantage of a good year
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 259 ⟶ 304:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walkbridge, FY24 to FY25 <sup>p. 16</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying Earningsearnings
|-
| style="text-align:left" | FY24
Line 288 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m.
 
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* '''Underlying Earnings''' +9% (change at constant FX) <sup>p. 16</sup>
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* '''Better underwriting result''' from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* '''Increase in investment income''' reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR.
* '''Higher unwind of discount''' of claims reserves, in line with guidance <sup>p. 16</sup>
* '''Unfavorable forex impact''' notably due to USD depreciation vs. EUR <sup>p. 16</sup>
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 299 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP &and other revenues by segmentline, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 17.3
| style="text-align:right" | 19.0
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | —
| style="text-align:right" | 9.3
| style="text-align:right" | 10.5
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | 6.0
| style="text-align:right" | 69.10
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.9
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left; font-weight:bold" | TotalHealth GWP
| style="text-align:right; font-weight:bold" | 3417.5
| style="text-align:right; font-weight:bold" | 3719.50
| style="text-align:right; font-weight:bold" | +5%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Individual
| style="text-align:right" | —
| style="text-align:right" | 10.5
| style="text-align:right" | 11.1
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
| style="text-align:right" | 7.0
| style="text-align:right" | 78.95
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" | TotalEmployee Benefits GWP
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 1912.09
| style="text-align:right; font-weight:bold" | +4%
|}
</div>
Line 359 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flowsFY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
 
* '''Life GWP & Other Revenues''' +9% (change at constant scope and FX) <sup>p. 17</sup>
* '''Health GWP & Other Revenues''' +5% (change at constant scope and FX) <sup>p. 17</sup>
* '''Net flows''': EUR +5.4bn vs. EUR +1.5bn in FY24 <sup>p. 17</sup>
* '''Employee Benefits''' (including both short-term and long-term Employee Benefits GWP and other revenues) FY25: EUR 12.9bn (+4% vs. FY24) <sup>p. 17</sup>
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
 
<div style="overflow-x:auto">
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) <sup>p. 18</sup>
{| class="wikitable fintable"
* (bar) '''PVEP''' -2% <sup>p. 18</sup>
**|+ FY24PVEP Total:trend by segment, FY24 EURvs 50.9bnFY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
*** '''Protection & Health''': EUR 39.4bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY24
*** '''Unit-Linked''': EUR 8.5bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY25
*** '''Capital-light G/A''': EUR 2.0bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | LFL Change
*** '''Traditional G/A''': EUR 1.0bn <sup>p. 18</sup>
|-
** FY25 Total: EUR 49.4bn <sup>p. 18</sup>
| style="text-align:left; font-weight:bold" | Total PVEP
*** '''Protection & Health''': EUR 31.4bn (-4%) <sup>p. 18</sup>
| style="text-align:right; font-weight:bold" | 50.9
*** '''Unit-Linked''': EUR 8.5bn (+18%) <sup>p. 18</sup>
| style="text-align:right; font-weight:bold" | 49.4
*** '''Capital-light G/A''': EUR 7.8bn (-10%) <sup>p. 18</sup>
| style="text-align:right; font-weight:bold" | -2%
*** '''Traditional G/A''': EUR 1.7bn (-10%) <sup>p. 18</sup>
|-
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
| style="text-align:left" | Protection & Health
* (bar) '''NB CSM''' (pre-tax) +3% <sup>p. 18</sup>
| style="text-align:right" | —
** FY24: EUR 2.2bn <sup>p. 18</sup>
| style="text-align:right" | 31.4
** FY25: EUR 2.2bn <sup>p. 18</sup>
| style="text-align:right" | -4%
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
|-
* (bar) '''NBV''' (post-tax) stable <sup>p. 18</sup>
| style="text-align:left" | Unit-Linked
** FY24: EUR 2.3bn <sup>p. 18</sup>
| style="text-align:right" | —
** FY25: EUR 2.2bn <sup>p. 18</sup>
| style="text-align:right" | 8.5
** '''NBV margin''': FY24 4.4%, FY25 4.5% <sup>p. 18</sup>
| style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:right" | —
| style="text-align:right" | 7.8
| style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|}
</div>
 
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
 
<div style="overflow-x:auto">
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) <sup>p. 19</sup>
{| class="wikitable fintable"
* (waterfall) '''Contractual Service Margin rollforward''':
**|+ Contractual Service Margin rollforward, FY24: EURto 33.6bnFY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
** '''New business CSM''': +EUR 2.2bn <sup>p. 19</sup>
! class="col-s" style="text-align:right" | Value
** '''Underlying return on in-force''': +EUR 1.3bn <sup>p. 19</sup>
|-
** '''CSM release''': -EUR 3.0bn <sup>p. 19</sup>
| style="text-align:left" | FY24
** '''Economic variance''': +EUR 0.6bn <sup>p. 19</sup>
| style="text-align:right" | 33.6
** '''Operating variance''': -EUR 0.3bn <sup>p. 19</sup>
|-
** '''Affiliates, FX & other''': -EUR 1.4bn <sup>p. 19</sup>
| style="text-align:left" | New business CSM
** FY25: EUR 33.0bn <sup>p. 19</sup>
| style="text-align:right" | +2.2
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
|-
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
| style="text-align:left" | Underlying return on in-force
* '''FX impact''' mainly from JPY and HKD depreciation <sup>p. 19</sup>
| style="text-align:right" | +1.3
* '''CSM o/w Life''': FY24 EUR 25.8bn, FY25 EUR 25.4bn <sup>p. 19</sup>
|-
* '''CSM o/w Health''': FY24 EUR 7.7bn, FY25 EUR 7.6bn <sup>p. 19</sup>
| style="text-align:left" | CSM release
| style="text-align:right" | -3.0
|-
| style="text-align:left" | Economic variance
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.3
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -1.4
|-
| style="text-align:left" | FY25
| style="text-align:right" | 33.0
|}
</div>
 
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
 
<div style="overflow-x:auto">
* '''Underlying Earnings''' +7% (change at constant FX) <sup>p. 20</sup>
{| class="wikitable fintable"
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
**|+ FY24:Underlying EURearnings 3bridge,323m FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
** '''Short-term technical margin''': +EUR 60m <sup>p. 20</sup>
! class="col-s" style="text-align:right" | Underlying earnings
** '''Long-term result incl. CSM release''': +EUR 156m <sup>p. 20</sup>
|-
** '''Financial result''': -EUR 11m <sup>p. 20</sup>
| style="text-align:left" | FY24 start
** '''Tax, FX and others''': -EUR 27m <sup>p. 20</sup>
| style="text-align:right" | 3,323
** FY25: EUR 3,501m <sup>p. 20</sup>
|-
*** '''Short-term technical margin''': EUR 479m <sup>p. 20</sup>
| style="text-align:left" | Short-term technical margin
*** '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup>
| style="text-align:right" | +60
*** '''Financial result''': EUR 946m <sup>p. 20</sup>
|-
*** '''Tax & others''': -EUR 728m <sup>p. 20</sup>
| style="text-align:left" | Long-term result incl. CSM release
* '''Strong short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>
| style="text-align:right" | +156
* '''Higher long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
|-
* '''Underlying Earnings o/w Life''': FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) <sup>p. 20</sup>
| style="text-align:left" | Financial result
* '''Underlying Earnings o/w Health''': FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) <sup>p. 20</sup>
| style="text-align:right" | -11
|-
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ==
* ''Short-term technical margin'': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
* ''Long-term result'' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
* ''Tax & others'': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
 
<div style="overflow-x:auto">
* '''Underlying earnings''' (constant FX) +6% to EUR 8.4bn (FY25) from EUR 8.1bn (FY24) <sup>p. 21</sup>
{| class="wikitable fintable"
** '''Property & Casualty''': EUR 5.9bn (+9%) <sup>p. 21</sup>
**|+ '''LifeEarnings &and Health''':net EURincome 3.5bnbreakdown (+7%)FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** '''Asset Management''': EUR 0.2bn (-57%) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | FY24
** '''Holdings & other''': EUR -1.2bn (stable) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | FY25
* '''Net income''' (reported) +26% to EUR 9.8bn (FY25) from EUR 7.9bn (FY24) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | Change
** '''Non-financial flows''': EUR +2.1bn (FY25) vs EUR -0.5bn (FY24) <sup>p. 21</sup>
|-
*** '''Capital gains from AXA IM disposal''': EUR +2.2bn (FY25) <sup>p. 21</sup>
| style="text-align:left" | Property & Casualty
** '''Financial flows''' (incl. RCG): EUR -0.7bn (FY25) vs EUR +0.3bn (FY24) <sup>p. 21</sup>
| style="text-align:right" | 5.5
* (bar) '''Underlying earnings per share''': EUR 3.86 (FY25) vs EUR 3.59 (FY24), +8% <sup>p. 21</sup>
| style="text-align:right" | 5.9
** +6% from earnings growth <sup>p. 21</sup>
| style="text-align:right" | +9%
** +3% from capital management <sup>p. 21</sup>
|-
** -2% from forex <sup>p. 21</sup>
| style="text-align:left" | Life & Health
*** Including -1% from temporary earnings dilution from AXA IM sale due to timing of anti-dilutive share buyback <sup>p. 21</sup>
| style="text-align:right" | 3.3
* '''Underlying earnings''' driven by strong performance from insurance businesses <sup>p. 21</sup>
| style="text-align:right" | 3.5
* '''Holding cost''' stable, expected to remain at current level in 2026 <sup>p. 21</sup>
| style="text-align:right" | +7%
* '''Net income''' mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
|-
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>
| style="text-align:left" | Asset Management
| style="text-align:right" | 0.4
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
 
<div style="overflow-x:auto">
* '''Shareholders' equity''' (Group share) <sup>p. 22</sup>
{| class="wikitable fintable"
** '''SHE (excl. OCI)''': EUR 54.0bn (FY25) vs EUR 52.7bn (HY25) vs EUR 58.0bn (FY24) <sup>p. 22</sup>
**|+ '''NetUnderlying OCI''':earnings EURper -6.8bnshare (FY25)bridge, vsFY24 EURto -7.2bn (HY25) vs EUR -8.1bn (FY24)FY25 <sup>p. 2221</sup>
! style="text-align:left" | EUR
** '''SHE (excl. OCI & undated subordinated debt)''': EUR 49.4bn (FY25) vs EUR 47.0bn (HY25) vs EUR 53.2bn (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | Underlying earnings per share
** '''Debt gearing''': 22.3% (FY25) vs 23.4% (HY25) vs 20.6% (FY24) <sup>p. 22</sup>
|-
** '''Underlying ROE''': 16.0% (FY25) vs 17.5% (HY25) vs 15.2% (FY24) <sup>p. 22</sup>
| style="text-align:left" | FY24
* '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25) and EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 3.59
* '''Change in Net OCI''': EUR 1.3bn (FY24 to FY25) and EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Net income for the period''': EUR 9.8bn (FY24 to FY25) and EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Earnings growth
* '''Dividend''': EUR -4.6bn (FY24 to FY25) <sup>p. 22</sup>
| style="text-align:right" | +6%
* '''Annual share buyback''': EUR -1.2bn (FY24 to FY25) <sup>p. 22</sup>
|-
* '''Anti-dilutive share buyback following the sale of AXA IM''': EUR -3.5bn (FY24 to FY25) and EUR -3.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Capital management
* '''Undated subordinated debt''' (including interest charges): EUR -0.3bn (FY24 to FY25) and EUR -1.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | +3%
* '''Forex''': EUR -3.5bn (FY24 to FY25) and EUR -0.1bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Other''': EUR -0.6bn (FY24 to FY25) and EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Forex
* '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25) and EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | -2%
|-
| style="text-align:left" | Temporary earnings dilution from AXA IM sale
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
 
* ''Underlying earnings'' drivers:
== Higher organic cash remittance and robust cash position at Holding ==
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
 
=== Shareholders' equity ===
=== Higher organic cash remittance and robust cash position at Holding ===
 
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NetShareholders' Cashequity Remittance, FY24 vs FY25roll-forward <sup>p. 2322</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | ''Opening Shareholders' equity''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | 1.3
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | 9.8
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | Net''Closing CashShareholders' Remittanceequity''
| style="text-align:right" | 747.72
| style="text-align:right" | 747.52
|}
</div>
 
=== Higher organic cash remittance and robust cash position at Holding ===
* FY24 breakdown: EUR 7.1bn (ordinary cash remittance) + EUR 0.6bn (proceeds related to in-force treaties²) <sup>p. 23</sup>
* '''Remittance ratio¹''': 82% (FY25) vs 82% (FY24) <sup>p. 23</sup>
* '''FY24 Cash position''': EUR 4.0bn <sup>p. 23</sup>
* '''Net cash remittance from subsidiaries''': +EUR 7.5bn <sup>p. 23</sup>
* '''Dividend''': -EUR 4.6bn <sup>p. 23</sup>
* '''Annual share buyback''': -EUR 1.2bn <sup>p. 23</sup>
* '''Anti-dilutive share buyback following the sale of AXA IM''': -EUR 3.5bn <sup>p. 23</sup>
* '''Holding costs and interest expenses''': -EUR 1.3bn <sup>p. 23</sup>
* '''Change in net debt''': +EUR 1.6bn <sup>p. 23</sup>
* '''M&A and other''': +EUR 3.1bn <sup>p. 23</sup>
* '''FY25 Cash position''': EUR 5.6bn <sup>p. 23</sup>
* ¹Based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>.
* ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>.
 
* (bar) ''Net cash remittance'' trend:
== Solvency II at 224% ==
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
** ''FY25'': EUR 7.5bn total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
| style="text-align:left" | Change in net debt
| style="text-align:right" | +1.6
|-
| style="text-align:left" | M&A and other
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
</div>
 
=== Solvency II at 224% ===
 
<div style="overflow-x:auto">
* (waterfall) '''Eligible Own Funds (EOF)''': EUR 56.4bn (FY25) vs EUR 55.9bn (FY24) <sup>p. 24</sup>
{| class="wikitable fintable"
** Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
*|+ (waterfall) '''Solvency CapitalII Requirementwalk, (SCR)''':FY24 EURto 25.2bn (FY25) vs EUR 25.9bn (FY24) <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** Changes: EUR 0.0bn, +EUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn <sup>p. 24</sup>
! class="col-s" style="text-align:right" | EOF
* (waterfall) '''Solvency II ratio''': 224% (FY25) vs 216% (FY24) <sup>p. 24</sup>
! class="col-s" style="text-align:right" | SCR
** '''Regulatory & model changes''': +0pts <sup>p. 24</sup>
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
** '''Normalized capital generation''': +28pts <sup>p. 24</sup>
|-
** '''Operating variance''': -1pt <sup>p. 24</sup>
| style="text-align:left" | FY24
** '''Economic & FX''': +4pts <sup>p. 24</sup>
| style="text-align:right" | 55.9
** '''Dividend & annual share buyback''': -24pts <sup>p. 24</sup>
| style="text-align:right" | 25.9
** '''Management actions, debt & other''': +2pts <sup>p. 24</sup>
| style="text-align:right" | 216
* (bar) '''Key sensitivities''' on Ratio as of December 31, 2025 (224%) <sup>p. 24</sup>
|-
** '''Interest rate +50bps''': +2 pts <sup>p. 24</sup>
| style="text-align:left" | Regulatory & model changes
** '''Interest rate -50bps''': -1 pt <sup>p. 24</sup>
| style="text-align:right" | +0.2
** '''Corporate spreads +50bps''': -1 pt <sup>p. 24</sup>
| style="text-align:right" | 0.0
** '''Euro Sovereign spreads +50bps¹''': -7 pts <sup>p. 24</sup>
| style="text-align:right" | +0
** '''Credit migration²''': -4 pts <sup>p. 24</sup>
|-
** '''Listed Equity (excl. PE & Infra) +25%''': -1 pt <sup>p. 24</sup>
| style="text-align:left" | Normalized capital generation
** '''Listed Equity (excl. PE & Infra) -25%''': +2 pts <sup>p. 24</sup>
| style="text-align:right" | +8.8
** '''PE & Infra +25%''': +14 pts <sup>p. 24</sup>
| style="text-align:right" | +0.6
** '''PE & Infra -25%''': -19 pts <sup>p. 24</sup>
| style="text-align:right" | +28
** '''Inflation swap curve +50bps''': -5 pts <sup>p. 24</sup>
|-
* ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>.
| style="text-align:left" | Operating variance
* ²Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
| style="text-align:right" | 224
|}
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II ratio as of December 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
|-
| style="text-align:left" | Interest rate +50bps
| style="text-align:right" | +2
|-
| style="text-align:left" | Interest rate -50bps
| style="text-align:right" | -1
|-
| style="text-align:left" | Corporate spreads +50bps
| style="text-align:right" | -1
|-
| style="text-align:left" | Euro Sovereign spreads +50bps
| style="text-align:right" | -7
|-
| style="text-align:left" | Credit migration
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
| style="text-align:left" | PE & Infra +25%
| style="text-align:right" | +14
|-
| style="text-align:left" | PE & Infra -25%
| style="text-align:right" | -19
|-
| style="text-align:left" | Inflation swap curve +50bps
| style="text-align:right" | -5
|}
</div>
 
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
 
<div style="overflow-x:auto">
* '''Ratio as of 31/12/2025''': 224% <sup>p. 25</sup>
{| class="wikitable fintable"
* '''Impact of the end of grandfathering period on January 1, 2026''': -10pts to 215% <sup>p. 25</sup>
**|+ EURSolvency 2.4bnII grandfatheredratio debt no longer eligible as capital from January 1, 2026impacts <sup>p. 25</sup>
! style="text-align:left" | Event
* '''Impact of Solvency II revision to come into effect in 1Q27''': +17pts¹ <sup>p. 25</sup>
! class="col-s" style="text-align:right" | Impact (pts)
** No change expected in organic capital generation <sup>p. 25</sup>
|-
** Additional capital flexibility <sup>p. 25</sup>
| style="text-align:left" | Solvency II ratio as of December 31, 2025
* ¹Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
== Thomas Buberl, Group CEO conclusion ==
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* Conclusion''Section divider'' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
== Conclusion ==
 
=== Conclusion ===
 
* '''Record results''', achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
== Q&A Full Year 2025 earnings ==
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* ''Q&A session'' for the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
* Date: February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''MeetInvestor ourRelations management'contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
** March''Follow us'': Roadshows in Europe and USwww.axa.com <sup>p. 29</sup>
 
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
<div style="overflow-x:auto">
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
{| class="wikitable"
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
**|+ JulyMeet 31:our HY26management Earningsevent Release in Parisschedule <sup>p. 29</sup>
! style="text-align:left" | Date
** September 21: AXA Investor Day in London <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
* '''Contact us''' <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
** Investor Relations: +33 1 40 75 48 42 <sup>p. 29</sup>
|-
** Email: investor.relations@axa.com <sup>p. 29</sup>
| style="text-align:left" | March
* '''Follow us''' <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Roadshows
** Website: www.axa.com <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Europe and US
** Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon <sup>p. 29</sup>
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
 
== Appendices ==
 
===* Section divider for ''Appendices'' <sup>p. ===30</sup>
 
=== Table of contents ===
* Appendices <sup>p. 30</sup>
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
 
<div style="overflow-x:auto">
* (stacked bar) '''Gross financial debt''' (EUR bn):
{| class="wikitable fintable"
** '''FY24''': Total EUR 19.2bn; Tier 1 EUR 3.5bn, Tier 2 EUR 10.8bn, Senior debt EUR 4.8bn <sup>p. 32</sup>
**|+ '''FY25''':Gross Total EUR 22.3bn; Tier 1 EUR 3.5bn, Tier 2 EUR 12.2bn, Seniorfinancial debt EUR 4.6bn <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** '''Jan 1st 2026''' (End of the grandfathering period): Total EUR 20.3bn; Tier 1 EUR 5.8bn (o/w EUR 0.4bn redeemed in Jan 2026), Tier 2 EUR 11.3bn, Senior debt EUR 3.2bn <sup>p. 32</sup>
! class="col-s" style="text-align:right" | FY24
* '''Debt gearing''': 20.6% for FY24; 22.3% for FY25 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | FY25
* (stacked bar) '''Contractual maturity breakdown''' (EUR bn):
! class="col-s" style="text-align:right" | Jan 1st 2026
** '''2025''': Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 <sup>p. 32</sup>
|-
** '''2026''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:left" | Tier 1
** '''2027''': Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:right" | 4.8
** '''2028''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:right" | 4.6
** '''2029''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:right" | 3.2
** '''2030''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
|-
** '''2031-2039''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:left" | Tier 2
** '''≥2040''': Senior debt 10.8, Tier 2 0.2, Tier 1 1.4 <sup>p. 32</sup>
| style="text-align:right" | 10.8
** '''Undated''': Senior debt 4.6, Tier 2 0.7, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:right" | 12.2
* '''o/w Grandfathered debt''' (Contractual maturity, EUR bn):
| style="text-align:right" | 11.3
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
|-
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
| style="text-align:left" | Senior debt
** '''Undated''': Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:right" | 3.5
* (stacked bar) '''Economic maturity breakdown''' (EUR bn):
| style="text-align:right" | 3.5
** '''2025''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
| style="text-align:right" | 5.8
** '''2026''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
|-
** '''2027''': Senior debt 2.4, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
| style="text-align:left; font-weight:bold" | Total
** '''2028''': Senior debt 2.0, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
| style="text-align:right; font-weight:bold" | 19.2
** '''2029''': Senior debt 0.9, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
| style="text-align:right; font-weight:bold" | 20.3
** '''2030''': Senior debt 0.7, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
| style="text-align:right; font-weight:bold" | 20.3
** '''2031-2039''': Senior debt 6.4, Tier 2 0.2, Tier 1 1.5 <sup>p. 32</sup>
|-
** '''≥2040''': Senior debt 0.5, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
| style="text-align:left" | Debt gearing
** '''Undated''': Senior debt 4.0, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
| style="text-align:right" | 20.6%
* '''o/w Grandfathered debt''' (Economic maturity, EUR bn):
| style="text-align:right" | 22.3%
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
| style="text-align:right" | —
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
|}
** '''Undated''': Tier 1 0.8 <sup>p. 32</sup>
</div>
* Nominal debt <sup>p. 32</sup>
* In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
* For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for the purpose of this diagram <sup>p. 32</sup>
* This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable <sup>p. 32</sup>
* Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time <sup>p. 32</sup>
 
=== General Account invested assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Contractual Totalmaturity General Account invested assets, EUR 450bnbreakdown <sup>p. 3332</sup>
! style="text-align:left" | AssetEUR typebillion
! class="col-s" style="text-align:right" | ShareTier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | Fixed income2028
| style="text-align:right" | 77%
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Real estate2030
| style="text-align:right" | 9%
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | Infrastructure equity2031-2039
| style="text-align:right" | 2%
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Listed equities≥2040
| style="text-align:right" | 2%
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Private equity and hedge fundsUndated
| style="text-align:right" | 5%4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | CashGrandfathered debt (contractual)
| style="text-align:right" | 4%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | PolicyTier loans1 Undated
| style="text-align:right" | 0%1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
Line 680 ⟶ 1,041:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ InvestedEconomic assetsmaturity by type, FY25breakdown <sup>p. 3332</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
 
=== General account invested assets ===
 
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets breakdown FY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left; padding-left:1.5em" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left; padding-left:1.5em" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left; padding-left:1.5em" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left; font-weight:bold" | ''Total Insurance Invested Assets''
| style="text-align:right; font-weight:bold" | 450
| style="text-align:right; font-weight:bold" | 100%
|}
</div>
 
=== Structured and private credit assets ===
Duration gap: -0.4 year <sup>p. 33</sup>
¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
² '''Listed equities''' includes hedges; Listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
³ '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
⁴ Please refer to the financial supplement for more details <sup>p. 33</sup>
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ InvestedStructured assetsand byprivate credit assets type,breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | ''Total Structured and Private Credit Assets''
| style="text-align:right; font-weight:bold" | ''69''
| style="text-align:right; font-weight:bold" | ''15%''
| style="text-align:right" | o/w 54% participating
|}
</div>
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 34</sup>
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 34</sup>
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
* Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
* o/w 54% participating <sup>p. 34</sup>
* G/A: General Account <sup>p. 34</sup>
 
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed Income reinvestment ===
 
=== Investment portfolio | Fixed income reinvestment ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment byasset type, EUR 57bn totalmix <sup>p. 35</sup>
! style="text-align:left" | SegmentAsset mix
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Average rating
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | A
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
| style="text-align:right" | —
|}
</div>
Line 815 ⟶ 1,266:
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
Line 828 ⟶ 1,279:
|}
</div>
 
* Euro 57 billion fixed income invested at 3.9% <sup>p. 35</sup>
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit investedreinvestment of EUR 19.7bn at 4.7% (yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY) <sup>p. 35</sup>
** GradualStrategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* ¹ '''Government bonds & related''' refers to Government and Corporate bonds and related <sup>p. 35</sup>
* ² '''Private & Structured fixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
 
*=== '''Table of contents''': ===
 
** 1. Debt and Invested Assets, p.31 <sup>p. 36</sup>
** 2.''Debt Additionaland P&CInvested disclosures,Assets'' p.36on page 31 <sup>p. 36</sup>
** 3. ''Additional IFRS17P&C disclosures,'' on page p.4136 <sup>p. 36</sup>
** 4.''Additional Sustainability,IFRS17 p.44disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
 
* Well diversified across lines of business and geographies <sup>p. 37</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-s" style="text-align:right" | Share
Line 860 ⟶ 1,310:
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
Line 867 ⟶ 1,317:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
Line 881 ⟶ 1,331:
|}
</div>
* Leading market positions across lines <sup>p. 37</sup>
** Top 3 globally <sup>p. 37</sup>
*** Multinational Programs (Source: McKinsey) <sup>p. 37</sup>
*** Marine (Source: Aon, Guy Carpenter, and Global Market Insights) <sup>p. 37</sup>
*** Fine Art & Specie (Source: Industry Research Biz (January 2026)) <sup>p. 37</sup>
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup>
* (scatter plot) '''Profitability vs. Ex-price growth''':
** Property (top right) <sup>p. 37</sup>
** Specialty (middle right) <sup>p. 37</sup>
** Casualty (middle left) <sup>p. 37</sup>
** Professional lines (bottom left) <sup>p. 37</sup>
 
<div style="overflow-x:auto">
=== P&C | Focus on Reserves ===
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
 
=== P&C | Focus on reserves ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims reservesand ratio (Net undiscounted claimstechnical reserves/Net earned premiums)ratios <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 908 ⟶ 1,383:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
Line 918 ⟶ 1,393:
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
Line 927 ⟶ 1,402:
| style="text-align:right" | 180
| style="text-align:right" | 175
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
Line 953 ⟶ 1,413:
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
Line 964 ⟶ 1,424:
|}
</div>
* Technical reserves includedefinition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurancereinsurance Programprogram 1 ===
 
<div style="overflow-x:auto">
* Stable retention levels maintained in 2026 as in 2025 <sup>p. 39</sup>
{| class="wikitable fintable"
* (bar) '''Insurance segment (occurrence protection)''' in Euro:
**|+ '''EUInsurance Windstorm''':segment Capacityoccurrence EUR 4.0bn, Retention EUR 600mprotection <sup>p. 39</sup>
! style="text-align:left" | EUR
** '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>
! class="col-s" style="text-align:right" | Retention
** '''Europe Earthquake''': Capacity EUR 2.1bn, Retention EUR 400m <sup>p. 39</sup>
! class="col-m" style="text-align:right" | Capacity
** '''NA Hurricane''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>
|-
** '''NA Earthquake''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>
| style="text-align:left" | EU Windstorm
** '''Per other perils''': Capacity [unclear, visually around EUR 0.8bn], Retention EUR 400m <sup>p. 39</sup>
| style="text-align:right" | 600m
*** Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils <sup>p. 39</sup>
| style="text-align:right" | 4.0bn
*** Capacity varies by peril type <sup>p. 39</sup>
|-
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds <sup>p. 39</sup>
| style="text-align:left" | Europe Flood
* Excludes local reinsurance covers <sup>p. 39</sup>
| style="text-align:right" | 450m
* Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) <sup>p. 39</sup>
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 400m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
* Covered via ''Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
<div style="overflow-x:auto">
* '''Group underlying earnings deviation to average Nat Cat charges in 2026''' net of reinsurance, post-tax (in Euro billion) <sup>p. 40</sup>
{| class="wikitable fintable"
** (bar) '''More severe years - Negative deviation in ca. 40% of cases''':
***|+ 1/20yGroup (95thunderlying percentile):earnings -EURdeviation 1.2bnto average Nat Cat charges in 2026 <sup>p. 40</sup>
! style="text-align:left" | Return period / probability percentile
*** 1/10y (90th percentile): -EUR 0.8bn <sup>p. 40</sup>
! class="col-s" style="text-align:right" | EUR billion
*** 1/5y (80th percentile): -EUR 0.4bn <sup>p. 40</sup>
|-
** (bar) '''Median (50th percentile)''': EUR 0.1bn <sup>p. 40</sup>
| style="text-align:left" | 1/20y (95th percentile)
** (bar) '''Less severe years - Positive deviation in ca. 60% of cases''':
| style="text-align:right" | -1.2
*** 1/5y (20th percentile): EUR 0.5bn <sup>p. 40</sup>
|-
*** 1/10y (10th percentile): EUR 0.7bn <sup>p. 40</sup>
***| style="text-align:left" | 1/20y10y (5th90th percentile): EUR 0.8bn <sup>p. 40</sup>
| style="text-align:right" | -0.8
* '''Average Expected Nat Cat charges''' net of reinsurance, pre-tax (in Euro billion) <sup>p. 40</sup>
|-
** (bar) '''2025''': EUR 2.6bn; Estimated impact on GEP ca. 4.5% <sup>p. 40</sup>
| style="text-align:left" | 1/5y (80th percentile)
** (bar) '''2026''': EUR 2.7bn; Estimated impact on GEP ca. 4.5% <sup>p. 40</sup>
| style="text-align:right" | -0.4
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>
|-
* Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup>
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | EUR billion
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
| style="text-align:left" | 2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| class="col-s" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
 
=== Table of contents ===
 
* 1. ''Debt and Invested Assets'' <sup>p. 31</sup>
* 2. ''Additional P&C disclosures'' <sup>p. 36</sup>
* 3. ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* 4. ''Sustainability'' <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
 
<div style="overflow-x:auto">
* (flow) '''Technical Result''' (in EUR million, pre-tax) <sup>p. 42</sup>
{| class="wikitable fintable"
** '''Current Accident Year Undiscounted Technical Margin''': EUR 2,778 (change: +EUR 707) <sup>p. 42</sup>
***|+ '''GrossP&C Earnedmargin Premiums''':analysis EURand 57,656underlying (+6%)earnings FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million
*** '''Current Accident Year Undiscounted Combined Ratio''': 95.2% (-1.0pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | FY25
*** '''o/w Nat Cats''': 3.4% (-0.4pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | Change
** '''Current Accident Year Discounting''': EUR 2,009 (change: +EUR 115) <sup>p. 42</sup>
|-
*** '''Discounting Ratio''' (in Combined Ratio points): -3.5% (+0.0pt) <sup>p. 42</sup>
***| style="text-align:left" | '''Current Accident Year NetUndiscounted ClaimsTechnical reservesMargin''': EUR 19.0bn <sup>p. 42</sup>
| style="text-align:right" | 2,778
*** '''Duration''': 4.0 years <sup>p. 42</sup>
| style="text-align:right" | +707
*** '''Current Accident Year Discount Rate''': 2.8% <sup>p. 42</sup>
|-
** '''Prior Years' Reserve Development (PYD)''': EUR 622 (change: -EUR 341) <sup>p. 42</sup>
| style="text-align:left" | ''Current Accident Year Discounting''
*** '''PYD ratio''': -1.1% (+0.7pt) <sup>p. 42</sup>
| style="text-align:right" | 2,009
** '''Sensitivity to Current Accident Year discount rate changes''' <sup>p. 42</sup>
| style="text-align:right" | +115
*** +25bps: +EUR 0.2bn <sup>p. 42</sup>
|-
*** -25bps: -EUR 0.2bn <sup>p. 42</sup>
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
* (flow) '''Financial Result''' (in EUR million, pre-tax) <sup>p. 42</sup>
| style="text-align:right" | 622
** '''Investment Income''': EUR 3,988 (change: +EUR 435) <sup>p. 42</sup>
| style="text-align:right" | -341
*** '''FY25 Average Assets''': EUR 115bn <sup>p. 42</sup>
|-
*** '''Asset book yield''': 3.5% <sup>p. 42</sup>
| style="text-align:left" | ''Investment Income''
*** '''FY25 Reinvestment yield¹''': 4.3% <sup>p. 42</sup>
| style="text-align:right" | 3,988
** '''Insurance Finance Expenses''': -EUR 1,358 (change: -EUR 235) <sup>p. 42</sup>
| style="text-align:right" | +435
*** '''FY24 Reserves at locked-in rate''': EUR 71bn <sup>p. 42</sup>
|-
*** '''Liability book yield''': 1.9% <sup>p. 42</sup>
**| style="text-align:left" | '''2025 Insurance Finance Expenses''' (pre-tax): ~EUR -1.4bn <sup>p. 42</sup>
| style="text-align:right" | -1,358
** '''Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount''' <sup>p. 42</sup>
| style="text-align:right" | -235
*** +25bps: ~EUR -50m <sup>p. 42</sup>
|-
*** -25bps: ~EUR +50m <sup>p. 42</sup>
*| (flow)style="text-align:left" | '''Underlying Earnings before tax''': EUR 8,040 (change: +EUR 681) <sup>p. 42</sup>
| style="text-align:right" | 8,040
** '''Tax''': -EUR 2,060 (change: -EUR 169) <sup>p. 42</sup>
| style="text-align:right" | +681
** '''Affiliates, Minority interests & Other''': -EUR 108 (change: -EUR 10) <sup>p. 42</sup>
|-
** '''Underlying Earnings''': EUR 5,872 (change: +EUR 501) <sup>p. 42</sup>
| style="text-align:left" | Tax
*** '''Growth vs. FY24''' (at constant FX): +9% <sup>p. 42</sup>
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
* Includes''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* (flow) '''TechnicalShort-term technical Result'margin'' (in+EUR 60m to EUR million479m, pre-tax)including the recapture of Laya <sup>p. 43</sup>.
** '''Short-termGross Technicalearned Marginpremiums''': EUR+10% 479to (change: +EUR 60)17,416m <sup>p. 43</sup>.
*** Includes''All recaptureyear ofcombined Layaratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
*** '''GrossLong-term Earnedtechnical Premiumsmargin''': +EUR 17,416156m (+10%)to EUR 2,804m <sup>p. 43</sup>.
*** ''CSM release''All Year+EUR Combined215m Ratio''':to EUR 97.2% (-0.1pts),954m <sup>p. 43</sup>.
** '''Long-term Technical Marginexperience''': decreased EUR 2,80458m (change:to +EUR 156)-150m <sup>p. 43</sup>.
*** '''CSMInvestment releaseincome''': (non-VFA only) decreased EUR 2,9541m to (+EUR 215)2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
*** '''Technical experience''': -EUR 150 (-EUR 58) <sup>p. 43</sup>
** '''LifeInsurance &finance Healthexpenses'' FY25(non-VFA CSMonly) Keyincreased Sensitivities'''EUR (in9m to EUR billion)-1,538m <sup>p. 43</sup>.
*** '''BaselineReserves at locked-in rate''': 33(FY24) at EUR 62bn with a liability book yield of 2.35% <sup>p. 43</sup>.
 
*** '''Interest rates''' +50bps: -0.8 <sup>p. 43</sup>
<div style="overflow-x:auto">
*** '''Interest rates''' -50bps: 0.6 <sup>p. 43</sup>
{| class="wikitable fintable"
*** '''Sovereign spreads''' +50bps: -1.9 <sup>p. 43</sup>
***|+ '''SovereignTechnical spreads'''and -50bps:financial 1.9results in Euro million, pre-tax <sup>p. 43</sup>
! style="text-align:left" | Technical and Financial Results
*** '''Corporate spread''' +50bps: -0.8 <sup>p. 43</sup>
! class="col-s" style="text-align:right" | FY25
*** '''Corporate spread''' -50bps: 0.8 <sup>p. 43</sup>
! class="col-s" style="text-align:right" | Change
*** '''Equities''' +25%: 1.8 <sup>p. 43</sup>
|-
*** '''Equities''' -25%: -2.2 <sup>p. 43</sup>
| style="text-align:left" | Short-term Technical Margin
* (flow) '''Financial Result''' (in EUR million, pre-tax) <sup>p. 43</sup>
| style="text-align:right" | 479
** '''Investment Income''' (non-VFA only): EUR 2,484 (change: -EUR 1) <sup>p. 43</sup>
| style="text-align:right" | +60
*** '''FY25 Average Assets''': EUR 98bn <sup>p. 43</sup>
|-
*** '''Asset book yield''': 2.5% <sup>p. 43</sup>
| style="text-align:left" | Long-term Technical Margin
*** '''FY25 Reinvestment yield¹''': 3.8% <sup>p. 43</sup>
| style="text-align:right" | 2,804
** '''Insurance Finance Expenses''' (non-VFA only): -EUR 1,538 (change: -EUR 9) <sup>p. 43</sup>
| style="text-align:right" | +156
*** '''FY24 Reserves at locked-in rate''': EUR 62bn <sup>p. 43</sup>
|-
*** '''Liability book yield''': 2.5% <sup>p. 43</sup>
| style="text-align:left" | Investment Income (non-VFA only)
* (flow) '''Underlying Earnings before tax''': EUR 4,229 (change: +EUR 205) <sup>p. 43</sup>
| style="text-align:right" | 2,484
** '''Tax''': -EUR 800 (change: +EUR 65) <sup>p. 43</sup>
| style="text-align:right" | -1
** '''Affiliates, Minority interests & Other''': EUR 72 (change: -EUR 51) <sup>p. 43</sup>
|-
** '''Underlying Earnings''': EUR 3,501 (change: +EUR 219) <sup>p. 43</sup>
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
*** '''Growth vs. FY24''' (at constant FX): +7% <sup>p. 43</sup>
| style="text-align:right" | -1,538
* '''Invested assets''' (100%) (in EUR billion) <sup>p. 43</sup>
| style="text-align:right" | -9
** '''Residential Mortgages''': EUR 16 (4% of total G/A portfolio) <sup>p. 43</sup>
|}
*** EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup>
</div>
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup>
 
** '''CLO & ABS''': EUR 25 (6% of total G/A portfolio) <sup>p. 43</sup>
<div style="overflow-x:auto">
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup>
{| class="wikitable fintable"
** '''Infrastructure debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
***|+ SkewedUnderlying towardsearnings resilientbridge industriesin (Telecom,Euro Utilities, Transport)million <sup>p. 43</sup>
! style="text-align:left" | Underlying Earnings
** '''CRE debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
! class="col-s" style="text-align:right" | FY25
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup>
! class="col-s" style="text-align:right" | Change
** '''Mid-Market lending''': EUR 10 (2% of total G/A portfolio) <sup>p. 43</sup>
|-
*** Strong diversification with EUR 8m average ticket <sup>p. 43</sup>
| style="text-align:left" | Underlying Earnings before tax
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup>
| style="text-align:right" | 4,229
** '''Other''': EUR 2 (0% of total G/A portfolio) <sup>p. 43</sup>
| style="text-align:right" | +205
** '''Total Structured and Private Credit Assets''': EUR 69 (15% of total G/A portfolio) <sup>p. 43</sup>
|-
*** o/w 54% participating <sup>p. 43</sup>
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
 
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM key sensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | Baseline
| style="text-align:right" | 33.3
|-
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,095 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG targets and 2025 resultsachievements <sup>p. 45</sup>
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025Achieved Resultin 2025
|-
| style="text-align:left" | '''As a Global INVESTOR'''
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn² per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m² per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | '''AsTransition aunderwriting Global(cumulative INSURER'''2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | P&C GWP to support transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 Cumulative(cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers by 2026
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | '''AsClimate aadaptation COMPANY'''training
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | >80,000
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Net-Zero -50%⁷ by 2030 in absolute carbonCarbon emissions and offset of residual emissionsreduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% Reduction against 2019
|-
| style="text-align:left" | Percentage of AXA Group employees engaged inEmployee volunteering activities by 2026
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
* Target revised in 2025 <sup>p. 45</sup>
* Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. <sup>p. 45</sup>
* Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
Line 1,153 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings and scores, 2025 <sup>p. 46</sup>
! style="text-align:left" | ProviderRating Agency
! class="col-ms" style="text-align:right" | MetricScore
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | '''S&P Global''' percentile
| class="col-ms" style="text-align:right" | Percentile in Dow Jones Best-in-Class Europe & World indices97th
| class="col-m" style="text-align:right" | 97th
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | ScoreAAA
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | '''MSCI'''CDP
| class="col-ms" style="text-align:right" | ScoreB
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | '''CDP'''Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | Score17.0 - Low risk
| class="col-m" style="text-align:right" | B
|-
| style="text-align:left" | '''MorningstarFTSE Sustainalytics'''Russell
| class="col-ms" style="text-align:right" | ESG Risk Rating4.3/5
| class="col-m" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | '''FTSE Russell'''
| class="col-m" style="text-align:right" | Score in FTSE4Good Index Series
| class="col-m" style="text-align:right" | 4.3/5
|}
</div>
 
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>.
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* Results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p.scope 47</sup>includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** China''Africa'': L&S,Morocco Thailand(insurance activities L&Sand holding), theNigeria Philippines(insurance L&Sactivities and P&Cholding), Indonesia L&S and IndiaEgypt (Lifeinsurance activities disposed on March 11, 2024 and holding) businesses which are fully consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa'EME-LATAM'': MoroccoMexico (insurance activities), andColombia holding)(insurance andactivities), NigeriaBrazil (insurance activities and holding), Egyptand Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to net income <sup>p. 47</sup>.
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** Russia''Transversal (Reso)& (insuranceOther'' activities)scope whichincludes consolidatedAXA underAssistance, theAXA equityLiabilities methodManagers, AXA, and contributes only to theother netCentral incomeHoldings <sup>p. 47</sup>.
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
** AXA Mediterranean Holdings <sup>p. 47</sup>.
* ''Accounting standards'' comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>.
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>.
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>.
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>.
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''Other Revenues''': represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* '''New Business ValueContractual Service Margin (NBVNB CSM)''': a component of the valuecarrying amount of the asset or liability for newly issued insurance contracts during the currentperiod, yearrepresenting the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* ''New Business Value margin (NBV margin)'': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* '''NewPresent Businessvalue Valueof marginexpected (NBVpremiums margin(PVEP)''': ratiothe ofnew (i)business NBVvolume, representingequal to the present value ofat newlythe issuedtime contractsof duringissue of the currenttotal year,premiums expected to (ii)be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''OperatingTechnical variance'experience'': the variationconsists of the year-endimpacts CSM versuson the expectedunderlying atearnings opening due toof (i) the differencesdifference between realizedthe expected and expectedincurred cash-flows of the operationaldefined assumptionsperiod, (ii) changesthe inrisk assumptionsadjustment suchrelease, as(iii) mortality,the longevity,changes lapsesin andonerous expensescontracts, and (iiiiv) impactthe other long-term elements which are mainly composed of modelnon-attributable changesexpenses <sup>p. 48</sup>.
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
** Operating variance is net of reinsurance <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>.
** PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
* Thank you <sup>p. 49</sup>.
* Full Year 2025 Earnings <sup>p. 49</sup>.
* February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''ABS'AA'': Asset-BackedSenior bond Securitiesrating
* '''AEP'AAA'': AggregateSenior Exceedancebond Probabilityrating
* '''AI'ABS'': ArtificialAsset-Backed IntelligenceSecurities
* '''AMF'AEP'': Autorité desAggregate marchésExceedance financiersProbability
* '''APAC'AI'': Asia-PacificArtificial Intelligence
* ''AMF'': Autorité des marchés financiers
* '''AY''': Accident Year
* ''APAC'': Asia-Pacific
* '''BBA''': Benefits and Bonus Anticipated
* '''CDP'AXA IM'': CarbonAXA DisclosureInvestment ProjectManagers
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* '''CLO''': Collateralized Loan Obligation
* '''CRE'AY'': Commercial RealAccident EstateYear
* ''BBA'': Benefit-Bearing Account
* '''CSA''': Corporate Sustainability Assessment
* '''CSM'CDP'': ContractualCarbon ServiceDisclosure MarginProject
* '''CY'CLO'': CurrentCollateralized Loan YearObligation
* '''DPS'CRE'': DividendCommercial PerReal ShareEstate
* ''CSA'': Corporate Sustainability Assessment
* '''EME''': Emerging Markets
* '''EOF'CSM'': EligibleContractual OwnService FundsMargin
* '''EPS'CY'': Earnings PerCalendar ShareYear
* ''DPS'': Dividend Per Share
* '''ESG''': Environmental, Social, and Governance
* '''ESMA'EME'': European Securities andEmerging Markets Authority
* '''EU'EOF'': EuropeanEligible Own UnionFunds
* '''FX'EPS'': ForeignEarnings Per ExchangeShare
* ''ESG'': Environmental, Social, and Governance
* '''GAAP''': Generally Accepted Accounting Principles
* ''ESMA'': European Securities and Markets Authority
* '''GEP''': Gross Earned Premium
* '''GWP'EU'': Gross WrittenEuropean PremiumsUnion
* '''HKD'EUR'': Hong Kong DollarEuro
* '''HY'FX'': HighForeign YieldExchange
* ''GAAP'': Generally Accepted Accounting Principles
* '''IFE''': Insurance Finance Expenses
* ''GBP'': Great British Pound
* '''IFRS''': International Financial Reporting Standards
* '''IG'GEP'': InvestmentGross Earned GradePremium
* '''JPY'GWP'': JapaneseGross Written YenPremiums
* '''LATAM'HKD'': LatinHong Kong AmericaDollar
* '''LTV'HY'': Loan-to-ValueHigh Yield
* ''IFE'': Insurance Finance Expenses
* '''MSCI''': Morgan Stanley Capital International
* ''IFRS'': International Financial Reporting Standards
* '''MX''': Mexico
* '''NA'IG'': NorthInvestment AmericaGrade
* ''JPY'': Japanese Yen
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV'LATAM'': New BusinessLatin ValueAmerica
* ''LFL'': Like-for-Like
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS'LTV'': Net Promoter ScoreLoan-to-Value
* ''MSCI'': Morgan Stanley Capital International
* '''OCI''': Other Comprehensive Income
* '''PAA'NA'': Premium AllocationNorth ApproachAmerica
* ''NB CSM'': New Business Contractual Service Margin
* '''PE''': Private Equity
* '''PVEP'NBV'': PresentNew Business Value of Expected Profits
* '''PYD'NHG'': Prior Years'Nationale ReserveHypotheek DevelopmentGarantie
* '''RCG'NPS'': RevaluationNet CapitalPromoter GainsScore
* '''ROE'OCI'': ReturnOther OnComprehensive EquityIncome
* '''SCR'PAA'': SolvencyParticipating CapitalAccount RequirementAgreement
* '''SHE'PE'': Shareholders'Private Equity
* ''PVEP'': Present Value of Expected Profits
* '''SME''': Small and Medium-sized Enterprises
* ''PYD'': Prior Years' Reserve Development
* '''TVOG''': Time Value of Options and Guarantees
* ''RCG'': Reinsurance Capital Generation
* '''UEPS''': Underlying Earnings Per Share
* '''UK'ROE'': UnitedReturn on KingdomEquity
* '''US'SCR'': UnitedSolvency Capital StatesRequirement
* '''USD'SHE'': United StatesShareholders' DollarEquity
* '''VAT'SME'': ValueSmall and AddedMedium-sized TaxEnterprises
* '''VFA'TVOG'': VariableTime Value of Options Feeand ApproachGuarantees
* ''UEPS'': Underlying Earnings Per Share
* ''UK'': United Kingdom
* ''US'': United States
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach